Literature DB >> 25388198

Technological incorporation in the Unified Health System (SUS): the problem and ensuing challenges.

Reinaldo Guimarães1.   

Abstract

Technological incorporation is a central topic among the concerns regarding health care systems. This paper discusses the role of technology dynamics in health systems' cost increases, suggesting two different approaches - a 'pragmatic-economic' approach and a 'rational-defensive' approach - as guidelines to explain the reasons for this centrality. The paper shows how judicialization results from this situation and discusses two doctrinal views - 'reserve for contingencies' and 'rational use' - as the views that usually guide the debates in the courts and among health policy makers. The paper suggests that the attitude currently prevalent in the Brazilian judiciary system can prejudice the principle of equity by improperly evaluating the principle of integrality. We present a brief genealogy of HTA and a timeline of HTA in Brazil. We also discuss the relevance and the impact of Law 12401/2011, which regulates the principle of integrality in the Unified Health System (SUS) and propose three challenges to the development of HTA actions aiming at technology incorporation in Brazil. Finally, we discuss the entry and the role of private health insurance companies, emphasizing changes in the scenario and in their position.

Entities:  

Mesh:

Year:  2014        PMID: 25388198     DOI: 10.1590/1413-812320141912.04642014

Source DB:  PubMed          Journal:  Cien Saude Colet        ISSN: 1413-8123


  3 in total

1.  (Un)Equitable distribution of health resources and the judicialization of healthcare: 10 years of experience in Brazil.

Authors:  Luciana de Melo Nunes Lopes; Francisco de Assis Acurcio; Semíramis Domingues Diniz; Tiago Lopes Coelho; Eli Iola Gurgel Andrade
Journal:  Int J Equity Health       Date:  2019-06-03

Review 2.  Administrative Data Linkage in Brazil: Potentials for Health Technology Assessment.

Authors:  M Sanni Ali; Maria Yury Ichihara; Luciane Cruz Lopes; George C G Barbosa; Robespierre Pita; Roberto Perez Carreiro; Djanilson Barbosa Dos Santos; Dandara Ramos; Nivea Bispo; Fabiana Raynal; Vania Canuto; Bethania de Araujo Almeida; Rosemeire L Fiaccone; Marcos E Barreto; Liam Smeeth; Mauricio L Barreto
Journal:  Front Pharmacol       Date:  2019-09-23       Impact factor: 5.810

3.  Cost-effectiveness of newer technologies for the diagnosis of Mycobacterium tuberculosis infection in Brazilian people living with HIV.

Authors:  Ricardo E Steffen; Marcia Pinto; Afranio Kritski; Anete Trajman
Journal:  Sci Rep       Date:  2020-12-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.